{
  "question_stem": {
    "en": "A 64-year-old man comes to the office with 2 months of episodic facial pain. He describes sudden-onset, severe, electric shock-like pain over the right cheek and ear lasting several seconds. The patient reports that activities like shaving and washing his face can trigger the pain and it is becoming more frequent. He is a retired veteran and has a history of posttraumatic stress disorder. Physical examination, including neurologic examination, is normal. Laboratory studies for blood cell counts, electrolytes, and hepatic and renal function are normal. The patient is started on a single drug therapy. On a follow-up visit 3 months later, he reports symptom improvement but is found to have the following blood counts:\n\nHemoglobin 9.0 g/dL\nReticulocytes 0.1%\nPlatelets 80,000/mm³\nLeukocytes 2,500/mm³",
    "zh": "一名64岁男性因阵发性面部疼痛就诊，病程2个月。他描述右脸颊和耳朵出现突发性、剧烈、电击样疼痛，持续数秒。患者报告说，剃须和洗脸等活动会诱发疼痛，并且疼痛变得越来越频繁。他是一名退休老兵，有创伤后应激障碍病史。体格检查，包括神经系统检查，均正常。血细胞计数、电解质、肝肾功能实验室检查均正常。患者开始接受单药治疗。3个月后的复诊时，他报告症状有所改善，但检查发现以下血细胞计数：\n\n血红蛋白 9.0 g/dL\n网织红细胞 0.1%\n血小板 80,000/mm³\n白细胞 2,500/mm³"
  },
  "question": {
    "en": "Which of the following is the most likely mechanism of action of the drug used in this patient?",
    "zh": "该患者所用药物最可能的药理作用机制是什么？"
  },
  "options": {
    "A": {
      "en": "Blocks NMDA receptors in hippocampal neurons",
      "zh": "阻断海马神经元中的 NMDA 受体"
    },
    "B": {
      "en": "Blocks serotonin reuptake on multiple levels",
      "zh": "在多水平上阻断血清素再摄取"
    },
    "C": {
      "en": "Decreases calcium current in thalamic neurons",
      "zh": "减少丘脑神经元中的钙离子电流"
    },
    "D": {
      "en": "Decreases sodium current on multiple levels",
      "zh": "在多水平上减少钠离子电流"
    },
    "E": {
      "en": "Increases chloride current on multiple levels",
      "zh": "在多水平上增加氯离子电流"
    }
  },
  "correct_answer": "D",
  "explanation": {
    "en": "This patient has trigeminal neuralgia (tic douloureux), a neuropathic disorder that typically presents with episodic, severe, unilateral, electric shock-like pain in the distribution of CN V. Symptoms are often triggered by innocuous stimuli such as shaving or washing the face. The first-line treatment of trigeminal neuralgia is carbamazepine, a medication that inhibits neuronal high-frequency firing by reducing the ability of sodium channels to recover from inactivation (ie, sodium channel blockade).\n\nCarbamazepine may cause the following important adverse effects:\n\n1.  Bone marrow suppression, which may lead to anemia, agranulocytosis, and thrombocytopenia (complete blood cell counts should be monitored periodically)\n2.  Hyponatremia, due to increased sensitivity to antidiuretic hormone\n\n(Choice A) Ketamine, felbamate, and memantine are examples of medications that block NMDA receptors. Ketamine is used as a general anesthetic agent, felbamate is an anticonvulsant, and memantine may be effective in the treatment of Alzheimer dementia.\n\n(Choice B) Selective serotonin reuptake inhibitors (eg, fluoxetine, sertraline) are typically used to treat depression, anxiety, and posttraumatic stress disorder. Side effects may include headache, worsening anxiety/agitation, and insomnia.\n\n(Choice C) Ethosuximide blocks T-type Ca2+ channels and decreases calcium current in thalamic neurons. This anticonvulsant is the agent of choice for absence seizures. Major side effects include gastrointestinal symptoms and drowsiness.\n\n(Choice E) Various antiseizure medications (eg, benzodiazepines, barbiturates) act on the GABA-A receptor to increase chloride conductance; however, carbamazepine does not significantly affect chloride channels.\n\nEducational objective:\nThe first-line treatment for trigeminal neuralgia is carbamazepine, a medication that inhibits neuronal high-frequency firing by blocking sodium channels. Carbamazepine can cause bone marrow suppression; therefore, complete blood cell counts should be monitored periodically.",
    "zh": "该患者患有三叉神经痛（tic douloureux），这是一种神经性疾病，通常表现为CN V分布区域的阵发性、剧烈、单侧、电击样疼痛。症状通常由剃须或洗脸等无害刺激引发。三叉神经痛的一线治疗是卡马西平，这是一种通过降低钠离子通道从失活中恢复的能力（即钠离子通道阻滞）来抑制神经元高频放电的药物。\n\n卡马西平可能引起以下重要不良反应：\n\n1. 骨髓抑制，可导致贫血、粒细胞缺乏症和血小板减少症（应定期监测全血细胞计数）\n2. 低钠血症，由于对抗利尿激素的敏感性增加\n\n（选项 A）氯胺酮、非巴mate和美金刚是阻断 NMDA 受体的药物的例子。氯胺酮用作全身麻醉剂，非巴mate是抗惊厥药，美金刚可能对治疗阿尔茨海默病有效。\n\n（选项 B）选择性血清素再摄取抑制剂（如氟西汀、舍曲林）通常用于治疗抑郁症、焦虑症和创伤后应激障碍。副作用可能包括头痛、焦虑/激动加重和失眠。\n\n（选项 C）乙琥胺阻断 T 型 Ca2+ 通道并减少丘脑神经元中的钙离子电流。这种抗惊厥药是失神发作的首选药物。主要副作用包括胃肠道症状和嗜睡。\n\n（选项 E）各种抗癫痫药物（如苯二氮卓类、巴比妥类）作用于 GABA-A 受体以增加氯离子电导；然而，卡马西平对氯离子通道没有显着影响。\n\n教育目标：\n三叉神经痛的一线治疗是卡马西平，这是一种通过阻断钠离子通道来抑制神经元高频放电的药物。卡马西平可引起骨髓抑制；因此，应定期监测全血细胞计数。"
  },
  "summary": {
    "en": "This question tests knowledge of trigeminal neuralgia treatment and the mechanism of action of carbamazepine. Carbamazepine is a first-line treatment for trigeminal neuralgia and works by blocking sodium channels. \n\nTo solve this question, recognize the clinical presentation of trigeminal neuralgia and recall the first-line treatment. Then, remember the mechanism of action of carbamazepine, which involves blocking sodium channels to reduce neuronal excitability.",
    "zh": "此问题测试对三叉神经痛的治疗和卡马西平的作用机制的了解。卡马西平是三叉神经痛的一线治疗药物，通过阻断钠离子通道发挥作用。\n\n要解决这个问题，需要识别三叉神经痛的临床表现并回忆起一线治疗。然后，记住卡马西平的作用机制，它涉及阻断钠离子通道以降低神经元兴奋性。"
  },
  "tags": "Trigeminal neuralgia; Carbamazepine; Sodium channels; Neuropathic pain; Bone marrow suppression; Neurology; Pharmacology",
  "category": "Neuro",
  "question_id": "1199",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Neuro 23\\1199",
  "extracted_at": "2025-11-05T15:13:10.975946",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:17:48.458141",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}